Effects of immunosuppressive drugs on in vitro neogenesis of human islets: Mycophenolate mofetil inhibits the proliferation of ductal cells

American Journal of Transplantation

Volumn 7, Issue 4, 2007, Pages 1021-1026

  Gao, R ^a   Ustinov, J ^a   Korsgren, O ^b   Otonkoski, T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Human islets; Immunosuppressive drugs; Neogenesis

Indexed keywords

DACLIZUMAB; DNA; IMMUNOSUPPRESSIVE AGENT; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INSULIN SYNTHESIS; PANCREAS CELL; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TOXICITY TESTING;

ANTIBODIES, MONOCLONAL; CELL CULTURE TECHNIQUES; CELL DIVISION; DNA; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS; MYCOPHENOLIC ACID; PANCREATIC DUCTS; SIROLIMUS; TACROLIMUS;

EID: 33947579517     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01728.x     Document Type: Article

References (34)

1. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen [see comments]. N Engl J Med 2000; 343: 230-238.
2. Ricordi C, Zeng YJ, Alejandro R et al. In vivo effect of FK506 on human pancreatic islets. Transplantation 1991; 52: 519-522.
3. Fabian MC, Lakey JRT, Rajotte RV, Kneteman NM. The efficacy and toxicity of rapamycin in murine islet transplantation: In vitro and in vivo studies. Transplantation 1993; 56: 1137-1142.
4. Paty BW, Harmon JS, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 2002; 73: 353-357.
5. Polastri L, Galbiati F, Bertuzzi F et al. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol 2002; 39: 229-233.
6. Bell E, Cao X, Moibi JA et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 2003; 52: 2731-2739.
7. Fotiadis C, Xekouki P, Papalois AE et al. Effects of mycophenolate mofetil vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats. World J Gastroenterol 2005; 11: 2733-2738.
8. Drachenberg CB, Klassen DK, Weir MR et al. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999; 68: 396-402.
9. Street CN, Lakey JR, Shapiro AM et al. Islet graft assessment in the Edmonton protocol: Implications for predicting long-term clinical outcome. Diabetes 2004; 53: 3107-3114.
10. Bussiere CT, Lakey JR, Shapiro AM, Korbutt GS. The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells. Diabetologia 2006; 49: 2341-2349.
11. Gao R, Ustinov J, Pulkkinen MA, Lundin K, Korsgren O, Otonkoski T. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 2003; 52: 2007-2015.
12. Gao R, Ustinov J, Korsgren O, Otonkoski T. In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells. Diabetologia 2005; 48: 2296-2304.
13. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420.
14. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. A second pathway for regeneration of adult exocrine and endocrine pancreas: A possible recapitulation of embryonic development. Diabetes 1993; 42: 1715-1720.
15. Gu D, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 1993; 118: 33-46.
16. Vinik A, Pittenger G, Rafaeloff R, Rosenberg L, Duguid WP. Determinants of pancreatic islet cell mass: A balance between neogenesis and senescence/apoptosis. Diabetes Rev 1996; 4: 235-263.
17. Bogdani M, Lefebvre V, Buelens N et al. Formation of insulinpositive cells in implants of human pancreatic duct cell preparations from young donors. Diabetologia 2003; 46: 830-838.
18. Bonner-Weir S, Taneja M, Weir GC et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000; 97: 7999-8004.
19. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells [see comments]. Nat Med 2000; 6: 278-282.
20. Tyrberg B, Eizirik DL, Hellerström C, Pipeleers DG, Andersson A. Human pancreatic β-cell deoxyribonucleic acid-synthesis in islet grafts decreases with increasing organ donor age but increases in response to glucose stimulation in vitro. Endocrinology 1996; 137: 5694-5699.
21. Lefebvre VH, Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG, Bouwens L. Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for beta-cells. Diabetes 1998; 47: 134-137.
22. Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835.
23. Hui H, Khoury N, Zhao X et al. Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes 2005; 54: 424-433.
24. Oetjen E, Baun D, Beimesche S et al. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. Mol Pharmacol 2003; 63: 1289-1295.
25. Li GD, Luo RH, Metz SA. Effects of inhibitors of guanine nucleotide synthesis on membrane potential and cytosolic free Ca2+ levels in insulin-secreting cells. Biochem Pharmacol 2000; 59: 545-556.
26. Borger P, Kauffman HF, Timmerman JA, Scholma J, van den Berg JW, Koeter GH. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. Transplantation 2000; 69: 1408-1413.
27. Azzola A, Havryk A, Chhajed P et al. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. Transplantation 2004; 77: 275-280.
28. Kirimlioglu H, Kirimlioglu V, Yilmaz S, Coban S, Turkmen E, Ara C. Liver pathology and cell proliferation after calcineurin inhibitors and antiproliferative drugs following partial hepatectomy in rats. Transplant Proc 2006; 38: 622-626.
29. Liu C, Schreiter T, Frilling A et al. Cyclosporine A FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro. World J Gastroenterol 2005; 11: 7602-7605.
30. Glomsda BA, Blaheta RA, Hailer NP. Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil. Spinal Cord 2003; 41: 610-619.
31. Blaheta RA, Bogossian H, Beecken WD et al. Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro. Transplantation 2003; 76: 1735-1741.
32. Cirulli V, Baetens D, Rutishauser U, Halban PA, Orci L, Rouiller DG. Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J Cell Sci 1994; 107: 1429-1436.
33. Kneteman NM, Lakey JRT, Wagner T, Finegood D. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation 1996; 61: 1206-1210.
34. Desai NM, Goss JA, Deng S et al. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: Local immunosuppression or islet toxicity? Transplantation 2003; 76: 1623-1625.